Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Cues for perception of synthetic and natural diphthongs in either noise or reverberation.

Nábĕlek AK, Ovchinnikov A, Czyzewski Z, Crowley HJ.

J Acoust Soc Am. 1996 Mar;99(3):1742-53.

PMID:
8819863
2.

Estimation of client-assessed hearing aid performance based upon unaided variables.

Crowley HJ, Nabelek IV.

J Speech Hear Res. 1996 Feb;39(1):19-27.

PMID:
8820696
3.

Vowel boundaries for steady-state and linear formant trajectories.

Nábĕlek AK, Czyzewski Z, Crowley HJ.

J Acoust Soc Am. 1993 Aug;94(2 Pt 1):675-87.

PMID:
8370873
4.

Pharmacologic actions of Ro 24-5913, a novel antagonist of leukotriene D4.

O'Donnell M, Crowley HJ, Yaremko B, O'Neill N, Welton AF.

J Pharmacol Exp Ther. 1991 Nov;259(2):751-8.

PMID:
1658310
5.

Pharmacology of a potent platelet-activating factor antagonist: Ro 24-4736.

Crowley HJ, Yaremko B, Selig WM, Janero DR, Burghardt C, Welton AF, O'Donnell M.

J Pharmacol Exp Ther. 1991 Oct;259(1):78-85.

PMID:
1656030
6.

Substituted (aryloxy)alkanoic acids as antagonists of slow-reacting substance of anaphylaxis.

LeMahieu RA, Carson M, Han RJ, Nason WC, O'Donnell M, Brown DL, Crowley HJ, Welton AF.

J Med Chem. 1987 Jan;30(1):173-8.

PMID:
3027332
7.

N-(heterocyclic alkyl)pyrido[2,1-b]quinazoline-8-carboxamides as orally active antiallergy agents.

Tilley JW, Levitan P, Lind J, Welton AF, Crowley HJ, Tobias LD, O'Donnell M.

J Med Chem. 1987 Jan;30(1):185-93.

PMID:
2879917
8.

Binding sites for 3H-LTC4 in membranes from guinea pig ileal longitudinal muscle.

Nicosia S, Crowley HJ, Oliva D, Welton AF.

Prostaglandins. 1984 Mar;27(3):483-94.

PMID:
6328581
9.

Ro 22-3747: a new antiallergic agent for the treatment of immediate hypersensitivity diseases.

Welton AF, Hope WC, O'Donnell M, Baruth H, Crowley HJ, Miller DA, Yaremko B.

J Pharmacol Exp Ther. 1984 Jan;228(1):57-64.

PMID:
6198511
10.

Antagonists of slow-reacting substance of anaphylaxis. 1. Pyrido[2,1-b]quinazolinecarboxylic acid derivatives.

Tilley JW, Levitan P, Welton AF, Crowley HJ.

J Med Chem. 1983 Nov;26(11):1638-42.

PMID:
6313920
11.
12.

In vitro studies on the mechanism of action of a new antiallergic, Ro 21-7634.

Welton AF, Hope WC, Crowley HJ, Salvador RA.

Agents Actions. 1981 Jul;11(4):345-51.

PMID:
6169263
13.

Biological activities of a chemically synthesized form of leukotriene E4.

Welton AF, Crowley HJ, Miller DA, Yaremko B.

Prostaglandins. 1981 Feb;21(2):287-96.

PMID:
6261299
14.

3-Phenyl-5-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]indole-2-carbonitrile, a potent inhibitor of prostaglandin synthetase and of platelet aggregation.

Fahrenholtz KE, Silverzweig MZ, Germane N, Crowley HJ, Simko BA, Dalton C.

J Med Chem. 1979 Aug;22(8):948-53.

PMID:
114655
15.

Trimethoquinol-different pharmacological properties of optical isomers.

Dalton C, Crowley HJ, Czyzewski LB.

Biochem Pharmacol. 1976 Oct 1;25(19):2209-10. No abstract available.

PMID:
971333
16.

Inhibition of platelet aggregation by papaverine-like drugs: evidence for a novel mechanism of action.

Shtacher G, Crowley HJ, Dalton C.

Biochem Pharmacol. 1976 May 1;25(9):1045-50. No abstract available.

PMID:
1267850
17.

Regional cyclic nucleotide phosphodiesterase activity in cat central nervous system: effects of benzodiazepines.

Dalton C, Crowley HJ, Sheppard H, Schallek W.

Proc Soc Exp Biol Med. 1974 Feb;145(2):407-10. No abstract available.

PMID:
4360638

Supplemental Content

Loading ...
Support Center